MedTrace Logo

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

NCT05390632 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-03

No results posted yet for this study

Summary

Investigating the performance of 18F-FDG PET/CT and PET/MRI in lymphomas

Conditions

  • PET/MRI

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Principal Investigators

  • Zhi Yang, PhD · Peking University Cancer Hospital & Institute

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2023-04-15
Completion
2023-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390632 on ClinicalTrials.gov